查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403437

穿戴式注射器市場至2030年的預測：按類型、使用類型、技術、應用、最終用戶和地區的全球分析

Wearable Injectors Market Forecasts to 2030 - Global Analysis By Type, By Usage Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球穿戴式注射器市場規模為 90.1 億美元，預計在預測期內將以 11.9%的年複合成長率成長，到2030年達到 198 億美元。

穿戴式注射器是穿戴在身體上的緊湊型醫療設備，有助於受控和一致的藥物輸送。這些設備透過皮下給藥藥物，為慢性病患者提供方便和精確的給藥。它們有多種形式，通常包含電子或機械系統，允許個體化治療計劃以及長時間連續或間歇性輸送藥物。

據國際糖尿病聯盟表示，到2045年，預計將有超過 7.8 億人患有糖尿病。

慢性病增加

隨著糖尿病、心血管疾病、自體免疫疾病等盛行率的不斷上升，對便捷、準確的給藥方式的需求日益成長。穿戴式注射器提供了一種解決方案，為患者提供了一種自我給藥的方法，確保給藥一致並提高治療醫囑遵從性。它為慢性病提供長期治療的能力推動市場成長，因為它滿足了患者增加便利性和有效管理持續健康挑戰的需求。

與穿戴式注射器相關的成本

與穿戴式注射器相關的成本因素是市場的一個重大抑制因素。由於技術先進、製造複雜性和專用材料，這些設備通常成本較高。這種高成本限制了一些患者的使用並影響了普及。此外，償付挑戰和醫療保健預算限制也阻礙了普及。

醫療基礎設施和文明病的增加

隨著醫療保健系統的發展，人們越來越重視以病人為中心的護理和創新的藥物輸送方法。穿戴式注射器順應了這一趨勢，提供了一種易於使用、自我給藥的方法來管理現代生活方式中普遍存在的慢性疾病。這種融合為穿戴式注射器創造了機會，可以滿足慢性病患者的需求，並提供高效、便利的藥物輸送解決方案，推動穿戴式注射器的採用和市場成長。

傾向於替代藥物傳輸系統

雖然患者和醫療保健提供者探索口服藥物和傳統注射等多種選擇，但穿戴式注射器的趨勢對市場成長構成了挑戰。病患偏好、成本考量以及競爭科技的發展等因素阻礙了穿戴式注射器的採用。這種趨勢可能會阻礙穿戴式注射器的普及，影響市場滲透率，並減緩預期的市場擴張，儘管它們具有準確和方便的藥物傳輸優勢。

COVID-19 的影響：

COVID-19 大流行對穿戴式注射器市場產生了重大影響。選擇性手術的延遲，患者就診的減少以及財務限制暫時減緩了穿戴式注射器的採用。然而，疫情凸顯了對遠距醫療解決方案的需求，隨著患者在醫療保健中斷的情況下尋求方便的家庭治療選擇，推動了對穿戴式注射器的長期興趣和創新。

預計糖尿病領域在預測期內將是最大的領域。

穿戴式注射器市場由糖尿病領域主導。隨著世界各地糖尿病盛行率的增加，對高效、便利的藥物傳輸系統的需求不斷成長。穿戴式注射器為糖尿病患者提供了一種便捷的方式來管理胰島素給藥，確保給藥準確並提高治療醫囑遵從性。此外，技術進步和專為糖尿病管理量身定做的方便用戶使用型整合系統的開拓進一步增強了該領域在市場上的主導地位。

預計離體注射器細分市場在預測期內年複合成長率最高

由於設備的攜帶性和彈性，離體注射器市場預計將出現顯著成長，這些設備允許用戶攜帶和方便地給藥，而不受佩戴在身上的限制。更謹慎和更易於使用的藥物輸送方法的趨勢，特別是對於需要間歇給藥或長期治療的治療，推動對外部注射器的需求。此外，與各種藥物的兼容性以及適應不同患者偏好的能力也有助於穿戴式注射器市場的擴大。

佔有率最大的地區

由於先進的醫療基礎設施，慢性病的高盛行率以及精通技術的人口的結合，北美預計將主導穿戴式注射器市場。該地區強大的法規環境支持創新醫療技術的採用。不斷成長的醫療保健支出和主要市場參與者的存在進一步增強了北美的領導地位。

年複合成長率最高的地區：

由於人口不斷成長，慢性病患病率上升以及醫療保健意識不斷增強，預計亞太地區穿戴式注射器市場將顯著成長。在中國、印度和日本等國家，積極的政府措施、改善的醫療基礎設施以及更多地採用創新技術促進市場擴張。此外，亞太地區可支配收入的增加以及向以患者為中心的醫療保健模式的轉變進一步推動了亞太地區穿戴式注射器的成長。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球穿戴式注射器市場：依類型

  • 身上
  • 離體

第6章 全球穿戴式注射器市場：依使用類型

  • 拋棄式
  • 半拋棄式
  • 可重複使用

第7章 全球穿戴式注射器市場：依科技分類

  • 微流控系統
  • 電子系統
  • 混合系統
  • 機械系統
    • 氣球儲液器
    • 點滴幫浦
    • 振動系統
    • 旋轉機構
    • 彈簧底座
  • 其他技術

第8章 全球穿戴式注射器市場：依應用分類

  • 自體免疫疾病
  • 循環系統疾病
  • 糖尿病
  • 免疫力缺乏
  • 感染疾病
  • 腫瘤學
  • 其他用途

第9章 全球穿戴式注射器市場：依最終用戶分類

  • 醫院
  • 診所
  • 居家護理
  • 其他最終用戶

第10章 全球穿戴式注射器市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Amgen Inc.
  • Becton, Dickinson and Company
  • CeQur SA
  • Debiotech SA
  • E3D Elcam Drug Delivery Devices
  • Enable Injection Devices Ltd.
  • Insulet Corporation
  • Medtronic plc
  • Nemera Development SA
  • ScPharmaceuticals Inc.
  • Sensile Medical AG
  • SFC Fluidics
  • SteadyMed Therapeutics, Inc.
  • Tandem Diabetes Care, Inc.
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Product Code: SMRC24662

According to Stratistics MRC, the Global Wearable Injectors Market is accounted for $9.01 billion in 2023 and is expected to reach $19.80 billion by 2030 growing at a CAGR of 11.9% during the forecast period. Wearable injectors are compact medical devices worn on the body, facilitating controlled and consistent drug delivery. These devices administer medication subcutaneously, offering convenience and precise dosing for patients with chronic conditions. They come in various forms, often incorporating electronic or mechanical systems, allowing for personalized treatment plans and enabling continuous or intermittent delivery of medications over extended periods.

According to the International Diabetes Federation, over 780 million people are expected to be living with diabetes, by 2045.

Market Dynamics:

Driver:

Increasing incidence of chronic illnesses

With an increasing prevalence of conditions like diabetes, cardiovascular diseases and autoimmune disorders, there's a growing demand for convenient and precise drug delivery methods. Wearable injectors offer a solution by providing patients with a means to self-administer medications, ensuring consistent dosing and improving treatment adherence. Their ability to accommodate long-term therapy for chronic conditions aligns with the need for enhanced patient convenience and efficient management of these ongoing health challenges, propelling their market growth.

Restraint:

Expenses associated with wearable injectors

The cost factor linked to wearable injectors poses a notable restraint in the market. These devices often entail high expenses due to their sophisticated technology, manufacturing intricacies, and specialized materials. This elevated cost can limit accessibility for some patients, impacting widespread adoption. Additionally, reimbursement challenges and healthcare budget constraints further impede their widespread use.

Opportunity:

Rising healthcare infrastructure and lifestyle disorders

As healthcare systems advance, there's increased emphasis on patient-centric care and innovative drug delivery methods. Wearable injectors align with this trend by offering a user-friendly, self-administered approach for managing chronic conditions prevalent in modern lifestyles. This convergence creates an opportunity for wearable injectors to address the needs of individuals with chronic illnesses, providing efficient and convenient drug delivery solutions, thereby fostering their adoption and market growth.

Threat:

Inclination towards alternative drug delivery systems 

While patients and healthcare providers explore diverse options like oral medications or traditional injections, the inclination away from wearable injectors challenges market growth. Factors such as patient preferences, cost considerations, and the development of competing technologies divert attention from wearable injector adoption. This trend might hinder the widespread acceptance of wearable injectors, impacting their market penetration and slowing the anticipated market expansion despite their advantages in precise and convenient drug delivery.

COVID-19 Impact:

The COVID-19 pandemic significantly influenced the wearable injectors market. Delayed elective procedures, reduced patient consultations and financial constraints led to a temporary slowdown in wearable injector adoption. However, the pandemic highlighted the need for remote healthcare solutions, potentially fostering long-term interest and innovation in wearable injectors as patients seek convenient, at-home treatment options amid healthcare disruptions.

The diabetes segment is expected to be the largest during the forecast period

The diabetes segment is poised to lead the wearable injectors market. With the escalating prevalence of diabetes worldwide, there's a growing demand for efficient and convenient drug delivery systems. Wearable injectors offer diabetic patients a way to manage insulin delivery conveniently, ensuring precise dosing and enhancing treatment adherence. Moreover, technological advancements and the development of user-friendly, integrated systems tailored for diabetes management further contribute to the dominance of this segment in the market.

The off-body injectors segment is expected to have the highest CAGR during the forecast period

The off-body injectors segment is set for substantial growth due to the device's portability and flexibility, allowing users to carry and administer medications conveniently without the constraints of being attached to the body. The trend towards more discreet and user-friendly drug delivery methods, especially for treatments requiring intermittent dosing or long-term therapies, drives the demand for off-body injectors. Additionally, their compatibility with various medications and their ability to accommodate diverse patient preferences contribute to their expansion within the wearable injectors market.

Region with largest share:

North America is expected to dominate the wearable injectors market due to a combination of advanced healthcare infrastructure, a high prevalence of chronic diseases and a tech-savvy population. The region's robust regulatory environment supports the adoption of innovative medical technologies. Rising healthcare expenditures and a strong presence of key market players further contribute to North America's leadership.

Region with highest CAGR:

Asia Pacific is positioned for significant growth in the wearable injectors market due to the region's expanding population, rising prevalence of chronic diseases and increasing healthcare awareness. Favorable government initiatives, improving healthcare infrastructure and the growing adoption of innovative technologies in countries like China, India, and Japan contribute to market expansion. Additionally, rising disposable incomes and a shift towards more patient-centric healthcare models in the region further propel the growth of wearable injectors in Asia Pacific.

Key players in the market:

Some of the key players in wearable injectors market include Amgen Inc., Becton, Dickinson and Company, CeQur SA, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injection Devices Ltd., Insulet Corporation, Medtronic plc, Nemera Development SA, ScPharmaceuticals Inc., Sensile Medical AG, SFC Fluidics, SteadyMed Therapeutics, Inc., Tandem Diabetes Care, Inc., Unilife Corporation, West Pharmaceutical Services, Inc. and Ypsomed Holding AG.

Key Developments:

In May 2023, Enable Injections, Inc. collaborated with Viridian Therapeutics, Inc., a U.S.-based biotechnology company.

In January 2023, Tandem Diabetes Care, Inc. announced the acquisition of AMF Medical SA, manufacturer of Sigi Patch Pump.

In June 2022, AbbVie received US FDA approval for SKYRIZI (risankizumab-rzaa) as the first and only specific interleukin-23 (IL-23) inhibitor for the treatment of adults with moderately to severely active Crohn's disease (CD). It can be self-administered by Subcutaneous Injection (SC) with an On-Body Injector (OBI).

Types Covered:

  • On-body
  • Off-body

Usage Types Covered:

  • Disposable
  • Semi-Disposable
  • Reusable

Technologies Covered:

  • Microfluidic Systems
  • Electronic Systems
  • Hybrid Systems
  • Mechanical Systems
  • Other Technologies

Applications Covered:

  • Autoimmune Disease
  • Cardiovascular Disease
  • Diabetes
  • Immunodeficiency
  • Infectious Disease
  • Oncology
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Wearable Injectors Market, By Type

  • 5.1 Introduction
  • 5.2 On-body
  • 5.3 Off-body

6 Global Wearable Injectors Market, By Usage Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Semi-Disposable
  • 6.4 Reusable

7 Global Wearable Injectors Market, By Technology

  • 7.1 Introduction
  • 7.2 Microfluidic Systems
  • 7.3 Electronic Systems
  • 7.4 Hybrid Systems
  • 7.5 Mechanical Systems
    • 7.5.1 Balloon Reservoir
    • 7.5.2 Infuser Pump
    • 7.5.3 Oscillatory Systems
    • 7.5.4 Rotary Mechanisms
    • 7.5.5 Spring-Based
  • 7.6 Other Technologies

8 Global Wearable Injectors Market, By Application

  • 8.1 Introduction
  • 8.2 Autoimmune Disease
  • 8.3 Cardiovascular Disease
  • 8.4 Diabetes
  • 8.5 Immunodeficiency
  • 8.6 Infectious Disease
  • 8.7 Oncology
  • 8.8 Other Applications

9 Global Wearable Injectors Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Home Care
  • 9.5 Other End Users

10 Global Wearable Injectors Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Amgen Inc.
  • 12.2 Becton, Dickinson and Company
  • 12.3 CeQur SA
  • 12.4 Debiotech SA
  • 12.5 E3D Elcam Drug Delivery Devices
  • 12.6 Enable Injection Devices Ltd.
  • 12.7 Insulet Corporation
  • 12.8 Medtronic plc
  • 12.9 Nemera Development SA
  • 12.10 ScPharmaceuticals Inc.
  • 12.11 Sensile Medical AG
  • 12.12 SFC Fluidics
  • 12.13 SteadyMed Therapeutics, Inc.
  • 12.14 Tandem Diabetes Care, Inc.
  • 12.15 Unilife Corporation
  • 12.16 West Pharmaceutical Services, Inc.
  • 12.17 Ypsomed Holding AG

List of Tables

  • Table 1 Global Wearable Injectors Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Wearable Injectors Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Wearable Injectors Market Outlook, By On-body (2021-2030) ($MN)
  • Table 4 Global Wearable Injectors Market Outlook, By Off-body (2021-2030) ($MN)
  • Table 5 Global Wearable Injectors Market Outlook, By Usage Type (2021-2030) ($MN)
  • Table 6 Global Wearable Injectors Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 7 Global Wearable Injectors Market Outlook, By Semi-Disposable (2021-2030) ($MN)
  • Table 8 Global Wearable Injectors Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 9 Global Wearable Injectors Market Outlook, By Technology (2021-2030) ($MN)
  • Table 10 Global Wearable Injectors Market Outlook, By Microfluidic Systems (2021-2030) ($MN)
  • Table 11 Global Wearable Injectors Market Outlook, By Electronic Systems (2021-2030) ($MN)
  • Table 12 Global Wearable Injectors Market Outlook, By Hybrid Systems (2021-2030) ($MN)
  • Table 13 Global Wearable Injectors Market Outlook, By Mechanical Systems (2021-2030) ($MN)
  • Table 14 Global Wearable Injectors Market Outlook, By Balloon Reservoir (2021-2030) ($MN)
  • Table 15 Global Wearable Injectors Market Outlook, By Infuser Pump (2021-2030) ($MN)
  • Table 16 Global Wearable Injectors Market Outlook, By Oscillatory Systems (2021-2030) ($MN)
  • Table 17 Global Wearable Injectors Market Outlook, By Rotary Mechanisms (2021-2030) ($MN)
  • Table 18 Global Wearable Injectors Market Outlook, By Spring-Based (2021-2030) ($MN)
  • Table 19 Global Wearable Injectors Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 20 Global Wearable Injectors Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Wearable Injectors Market Outlook, By Autoimmune Disease (2021-2030) ($MN)
  • Table 22 Global Wearable Injectors Market Outlook, By Cardiovascular Disease (2021-2030) ($MN)
  • Table 23 Global Wearable Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 24 Global Wearable Injectors Market Outlook, By Immunodeficiency (2021-2030) ($MN)
  • Table 25 Global Wearable Injectors Market Outlook, By Infectious Disease (2021-2030) ($MN)
  • Table 26 Global Wearable Injectors Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 27 Global Wearable Injectors Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Wearable Injectors Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Wearable Injectors Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Wearable Injectors Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 31 Global Wearable Injectors Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 32 Global Wearable Injectors Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.